Back to search
FDAFDA · Food and drugs·Recall number D-1293-2019

Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044

Published May 15, 2019 · Recall initiated: April 30, 2019

Summary

FDA records drug Class I recall D-1293-2019, published May 15, 2019 and initiated April 30, 2019. Recalling firm: Par Pharmaceutical, Inc.; Status: Terminated; Reported quantity: 4506 packs; Lot: AD812, exp 9/2020. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product

What to do

Voluntary: Firm initiated · Letter

Get an email if MYCOPHENOLATE MOFETIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MYCOPHENOLATE MOFETIL
Manufacturer
Par Pharmaceutical, Inc.
Distributor
nationwide
UPC
342023172044
Lot
AD812, exp 9/2020
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044 recalled?

Yes. FDA published recall D-1293-2019 on May 15, 2019. Reported hazard: Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MYCOPHENOLATE MOFETIL. UPC: 342023172044.